Trial Profile
Exploratory Study to Evaluate the Efficacy and Safety of CD07223 1.5% Gel and 0.5% Gel in Subjects With Acne
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2021
Price :
$35
*
At a glance
- Drugs Auriclosene (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Galderma
- 18 Sep 2014 New trial record